Literature DB >> 26216131

Expression and Function of PPARs in Cancer Stem Cells.

Yiming Zhang, Xu Zhang, Jing Wang, Yun Shen, Xiaoshan Tang, Fang Yu, Raorao Wang1.   

Abstract

Cancer stem cells (CSCs) are cancer cells with characteristics of stem cells, especially the ability to arise to all types of cell in a particular cancer tissue. With the capacity to generate multiple types of cancer cells, CSCs are proposed as primary impetus for tumor initiation and metastases and are suggested as potential therapeutic targets for anti-cancer treatment. Peroxisome-proliferator-activated receptors (PPARs) are a subset of multifunctional transcription factors which play a pivotal role in cancer development and tumorigenesis. PPARs are also reported to be involved in the modulation of the epithelial-mesenchymal transition (EMT) process in CSC initiation and in the regulation of CSC functions. However, the exact mechanisms remain unknown. Herein, we review the latest evidence on the regulatory effects and mechanisms of PPARs in CSC formation and function, and evaluate the prospects of PPARs as a target for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26216131     DOI: 10.2174/1574888x10666150728122921

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  10 in total

Review 1.  Emerging therapeutic targets in esophageal adenocarcinoma.

Authors:  Puja Gaur; Clayton R Hunt; Tej K Pandita
Journal:  Oncotarget       Date:  2016-07-26

Review 2.  Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis.

Authors:  Daniel Heudobler; Michael Rechenmacher; Florian Lüke; Martin Vogelhuber; Sebastian Klobuch; Simone Thomas; Tobias Pukrop; Christina Hackl; Wolfgang Herr; Lina Ghibelli; Christopher Gerner; Albrecht Reichle
Journal:  Front Pharmacol       Date:  2018-11-28       Impact factor: 5.810

3.  Study on <em>CCDC69</em> interfering with the prognosis of patients with breast cancer through PPAR signal pathway.

Authors:  Jinjiao Li; Panshi Zhang; Yun Xia
Journal:  Eur J Histochem       Date:  2021-02-22       Impact factor: 3.188

4.  Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.

Authors:  Bojiang Chen; Yu Zhang; Sisi Dai; Ping Zhou; Wenxin Luo; Zhoufeng Wang; Xuping Chen; Peng Cheng; Guoya Zheng; Jing Ren; Xiaodong Yang; Weimin Li
Journal:  Signal Transduct Target Ther       Date:  2021-01-08

5.  Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.

Authors:  Jing Xia; Shuhan Chen; Yaping Li; Hua Li; Minghong Gan; Jiashuo Wu; Clare Colette Prohaska; Yang Bai; Lu Gao; Li Gu; Dongfang Zhang
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

Review 6.  Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.

Authors:  Valdenizia R Silva; Luciano de S Santos; Rosane B Dias; Claudio A Quadros; Daniel P Bezerra
Journal:  Cancer Commun (Lond)       Date:  2021-11-17

Review 7.  Lipid Metabolism and Cancer.

Authors:  Hui Cheng; Meng Wang; Jingjing Su; Yueyue Li; Jiao Long; Jing Chu; Xinyu Wan; Yu Cao; Qinglin Li
Journal:  Life (Basel)       Date:  2022-05-25

Review 8.  Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.

Authors:  Wang Manni; Wu Min
Journal:  MedComm (2020)       Date:  2022-10-05

9.  Lack of associations between polymorphisms in SOD2 (rs2758331), NOS3 (rs1808593), PPARδ (rs9794 and rs10865710) and the risk of osteoarthritis in a Chinese Han population: a case-control study.

Authors:  Le-Cheng Zhang; Yong Hu; Cong Sui
Journal:  Chin Med J (Engl)       Date:  2019-05-05       Impact factor: 2.628

10.  Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma.

Authors:  Yu Jin; Xing Qin
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.